Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1991 1
1992 5
1993 4
1995 1
1996 1
1998 2
1999 2
2000 4
2001 4
2002 5
2003 8
2004 7
2005 12
2006 12
2007 10
2008 9
2009 9
2010 12
2011 8
2012 10
2013 9
2014 9
2015 12
2016 17
2017 12
2018 11
2019 13
2020 17
2021 11
2022 8
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

225 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic versus predictive value of biomarkers in oncology.
Oldenhuis CN, Oosting SF, Gietema JA, de Vries EG. Oldenhuis CN, et al. Among authors: gietema ja. Eur J Cancer. 2008 May;44(7):946-53. doi: 10.1016/j.ejca.2008.03.006. Epub 2008 Apr 7. Eur J Cancer. 2008. PMID: 18396036 Review.
Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial.
Smith MR, Scher HI, Sandhu S, Efstathiou E, Lara PN Jr, Yu EY, George DJ, Chi KN, Saad F, Ståhl O, Olmos D, Danila DC, Mason GE, Espina BM, Zhao X, Urtishak KA, Francis P, Lopez-Gitlitz A, Fizazi K; GALAHAD investigators. Smith MR, et al. Lancet Oncol. 2022 Mar;23(3):362-373. doi: 10.1016/S1470-2045(21)00757-9. Epub 2022 Feb 4. Lancet Oncol. 2022. PMID: 35131040 Free PMC article. Clinical Trial.
89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer.
Bensch F, van der Veen EL, Lub-de Hooge MN, Jorritsma-Smit A, Boellaard R, Kok IC, Oosting SF, Schröder CP, Hiltermann TJN, van der Wekken AJ, Groen HJM, Kwee TC, Elias SG, Gietema JA, Bohorquez SS, de Crespigny A, Williams SP, Mancao C, Brouwers AH, Fine BM, de Vries EGE. Bensch F, et al. Among authors: gietema ja. Nat Med. 2018 Dec;24(12):1852-1858. doi: 10.1038/s41591-018-0255-8. Epub 2018 Nov 26. Nat Med. 2018. PMID: 30478423 Clinical Trial.
Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial.
Sternberg CN, Skoneczna I, Kerst JM, Albers P, Fossa SD, Agerbaek M, Dumez H, de Santis M, Théodore C, Leahy MG, Chester JD, Verbaeys A, Daugaard G, Wood L, Witjes JA, de Wit R, Geoffrois L, Sengelov L, Thalmann G, Charpentier D, Rolland F, Mignot L, Sundar S, Symonds P, Graham J, Joly F, Marreaud S, Collette L, Sylvester R; European Organisation for Research and Treatment of Cancer Genito-Urinary Cancers Group; Groupe d'Etude des Tumeurs Urogénitales; National Cancer Research Institute Bladder Cancer Study Group; National Cancer Institute of Canada Clinical Trials Group; German Association of Urologic Oncology. Sternberg CN, et al. Lancet Oncol. 2015 Jan;16(1):76-86. doi: 10.1016/S1470-2045(14)71160-X. Epub 2014 Dec 11. Lancet Oncol. 2015. PMID: 25498218 Free article. Clinical Trial.
Reply to G. Wang et al.
Lubberts S, van Leeuwen FE, Schaapveld M, Gietema JA. Lubberts S, et al. Among authors: gietema ja. J Clin Oncol. 2023 Nov 1;41(31):4939-4940. doi: 10.1200/JCO.23.01336. Epub 2023 Aug 14. J Clin Oncol. 2023. PMID: 37579250 No abstract available.
The Sound of Silence: A Proxy for Platinum Toxicity.
Oldenburg J, Gietema JA. Oldenburg J, et al. Among authors: gietema ja. J Clin Oncol. 2016 Aug 10;34(23):2687-9. doi: 10.1200/JCO.2016.68.2476. Epub 2016 Jul 5. J Clin Oncol. 2016. PMID: 27382103 Free PMC article. No abstract available.
Magnesium and phosphorus.
Gietema JA, Meinardi MT, van der Graaf WT, Uges DR, Sleijfer DT. Gietema JA, et al. Lancet. 1998 Oct 31;352(9138):1476. doi: 10.1016/s0140-6736(05)61307-4. Lancet. 1998. PMID: 9808023 No abstract available.
Detection of anthracycline-induced cardiotoxicity.
Meinardi MT, van der Graaf WT, van Veldhuisen DJ, Gietema JA, de Vries EG, Sleijfer DT. Meinardi MT, et al. Among authors: gietema ja. Cancer Treat Rev. 1999 Aug;25(4):237-47. doi: 10.1053/ctrv.1999.0128. Cancer Treat Rev. 1999. PMID: 10448132 Review.
Whole-body CD8+ T cell visualization before and during cancer immunotherapy: a phase 1/2 trial.
Kist de Ruijter L, van de Donk PP, Hooiveld-Noeken JS, Giesen D, Elias SG, Lub-de Hooge MN, Oosting SF, Jalving M, Timens W, Brouwers AH, Kwee TC, Gietema JA, Fehrmann RSN, Fine BM, Sanabria Bohórquez SM, Yadav M, Koeppen H, Jing J, Guelman S, Lin MT, Mamounas MJ, Eastham JR, Kimes PK, Williams SP, Ungewickell A, de Groot DJA, de Vries EGE. Kist de Ruijter L, et al. Among authors: gietema ja. Nat Med. 2022 Dec;28(12):2601-2610. doi: 10.1038/s41591-022-02084-8. Epub 2022 Dec 5. Nat Med. 2022. PMID: 36471036 Free PMC article. Clinical Trial.
Cardio-Oncology: Progress in Diagnosis and Treatment of Cardiac Dysfunction.
Tromp J, Steggink LC, Van Veldhuisen DJ, Gietema JA, van der Meer P. Tromp J, et al. Among authors: gietema ja. Clin Pharmacol Ther. 2017 Apr;101(4):481-490. doi: 10.1002/cpt.614. Epub 2017 Feb 14. Clin Pharmacol Ther. 2017. PMID: 28073142 Review. No abstract available.
225 results